1. Registering for the Forum

    We require a human profile pic upon registration on this forum.

    After registration is submitted, you will receive a confirmation email, which should contain a link to confirm your intent to register for the forum. At this point, you will not yet be registered on the forum.

    Our Support staff will manually approve your account within 24 hours, and you will get a notification. This is to prevent the many spam account signups which we receive on a daily basis.

    If you have any problems completing this registration, please email support@jackkruse.com and we will assist you.

Low Cortisol Levels

Discussion in 'Optimal Labs' started by Eddie Garza, Apr 29, 2015.

  1. JanSz

    JanSz Gold

    The Man Who Corrected Einstein

     
  2. JanSz

    JanSz Gold



    2020's Biggest Breakthroughs in Math and Computer Science
    1,738,188 views
    Dec 23, 2020
     
  3. JanSz

    JanSz Gold



    The double copy: a new way to think about gravity - Dr. Christopher White

    upload_2021-7-11_21-45-34.png

    upload_2021-7-11_21-49-51.png
     
  4. JanSz

    JanSz Gold



    How To Read Feynman Diagrams
     
  5. JanSz

    JanSz Gold

    Laszlo G. Boros <contact@laszlogboros.com>
    Washington Post - J&J injections - FDA - Guillain-Barré warning
    ----------------------------
    FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
    https://www.laszlogboros.com/so/0dN...EwMDEtNTliYS00Y2VhLThjM2UtMmRmZmExN2YwZDM3In0
    -----------------------------

    FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
    The agency cites link to a small number of Guillain-Barré cases after vaccination but says the shot’s benefits outweigh the risk
    FDA issues new warning on Johnson & Johnson related to rare autoimmune disorder
    The Food and Drug Administration announced a new warning for the Johnson & Johnson coronavirus vaccine on July 12. (Reuters)
    By
    Laurie McGinley
    and
    Lena H. Sun

    July 12, 2021|Updated yesterday at 11:38 p.m. EDT
    The Food and Drug Administration announced a new warning for the Johnson & Johnson coronavirus vaccine on Monday, saying the shot has been linked to a serious but rare side effect called Guillain-Barré syndrome, in which the immune system attacks the nerves.

    About 100 preliminary reports of Guillain-Barré have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the United States, according to a companion statement from the Centers for Disease Control and Prevention, which monitors vaccine safety systems with the FDA. Of these reports, 95 were serious and required hospitalization, the FDA statement said. There was one death. Neither agency provided details about the death.

    The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older, according to the CDC. Most people fully recover from Guillain-Barré.

    Advertisement
    The warning on the Johnson & Johnson vaccine will be the latest blow to a shot that had been eagerly anticipated because of its ease of use — it requires only a single dose, which makes it especially helpful in immunizing harder-to-reach populations and regions. But the vaccine has been plagued by problems, including massive stumbles at its U.S. manufacturing plant.

    The latest development comes at an especially fraught moment, as the highly transmissible delta variant sweeps the country and fuels an increase in coronavirus cases in many states. And the new warning could complicate the Biden administration’s efforts to ramp up inoculations in areas where skepticism regarding coronavirus vaccines remains high and the vaccine rate is low.

    Available data do not show a pattern suggesting a similar increased risk of Guillain-Barré with the Pfizer-BioNTech and Moderna vaccines. More than 321 million doses of those vaccines — developed with a technology different from what is used to make the Johnson & Johnson vaccine — have been administered in the United States.

    The Guillain-Barré cases are expected to be discussed as part of an upcoming meeting of the CDC’s Advisory Committee on Immunization Practices, the agency said.

    The Johnson & Johnson coronavirus vaccine is a single shot, making it especially useful in areas where it might be harder to administer two shots. (Narendra Shrestha/EPA-EFE/Shutterstock)
    Although the available evidence suggests an association between the Johnson & Johnson vaccine and increased risk of Guillain-Barré, “it is insufficient to establish a causal relationship,” the FDA said.

    Advertisement
    Guillain-Barré syndrome usually occurs at a rate of about 60 to 120 cases each week, according to CDC data. While the cause is not fully understood, it often follows infection with a virus, including influenza, or bacteria. Each year in the United States, an estimated 3,000 to 6,000 people develop the illness.

    People older than 50 are at greatest risk. About two-thirds of people who develop the syndrome experience symptoms several days or weeks after they have fallen ill with diarrhea or a lung or sinus illness.

    Federal health officials have repeatedly emphasized that the benefits of the coronavirus inoculations far outweigh potential risks. The FDA said it had evaluated the available information for the Johnson & Johnson vaccine “and continues to find the known and potential benefits clearly outweigh the known and potential risks,” the agency said.

    Advertisement
    Johnson & Johnson declined Monday to comment.

    Reports of Guillain-Barré in vaccine recipients are rare, the CDC said, “but do likely indicate a small possible risk of this side effect following” the Johnson & Johnson vaccine. Reports of the syndrome were made to the Vaccine Adverse Events Reporting System, an early warning safety network run by the CDC and the FDA. It collects information about possible side effects or health problems after vaccination. The system looks for unusual or unexpected patterns that require a closer look. Anyone can report a reaction or injury.

    Experts said the latest news about the Johnson & Johnson shot may complicate vaccination efforts, especially in parts of the country where rates remain under 50 percent.

    Jeanne Marrazzo, director of infectious-diseases at the University of Alabama at Birmingham, said the absolute risk of Guillain-Barré remains so rare that “it should not deter people from getting vaccinated,” she wrote in an email. If people are concerned, they can still get a Pfizer or Moderna vaccine with no risk, adding: “This news does not provide an excuse to remain unvaccinated!!!!”

    Advertisement
    But the expected warning on the Johnson & Johnson shot “quite possibly” will make it harder for health-care providers to persuade people to roll up their sleeves, Marrazzo said.

    “When a person is hesitant to get a vaccine, any additional safety signal, even if very rare, just adds to their own database that fuels their reluctance,” Marrazzo wrote.

    Paul A. Offit, a pediatrician and director of the Vaccine Education Center at Children’s Hospital of Pennsylvania, said he did not think the latest news will make much difference because the U.S. vaccination effort has “hit a wall.” The Biden administration has already done “as good a job as we could possibly hope for on how to mass produce, mass distribute and mass vaccinate” the country, Offit said.

    Now, Offit said, it’s time for the next step: the government needs to compel vaccination. The Supreme Court has already ruled twice that public health authorities can take these measures in the face of outbreaks, he said. Without such a step, the virus is “going to continue to mutate, continue to create variants” and result in another surge in late fall and winter, he said.

    Advertisement
    Just three months ago, federal officials paused use of the Johnson & Johnson vaccine after it was linked to another rare side effect — severe blood clots. That pause was lifted within days after an extensive safety review by the FDA and the CDC, and a warning was added to the vaccine’s label.

    The vaccine also has been hobbled by production problems at Johnson & Johnson’s subcontractor, Emergent BioSolutions, the only U.S. manufacturer of the vaccine. The Baltimore plant was shut down in April after federal officials discovered millions of doses had been contaminated with the AstraZeneca vaccine, which was also being made there.

    Johnson & Johnson had to throw away the equivalent of about 75 million doses of the vaccine because of the problems at the Baltimore plant. About 40 million doses have been released for use. In response to the contamination, the Biden administration removed AstraZeneca manufacturing from the plant and put Johnson & Johnson in direct control of vaccine production there. But Emergent has not received authorization from the FDA to resume manufacturing the Johnson & Johnson product.

    Advertisement
    Other vaccines also have been associated with rare adverse events. The FDA in late June decided to add a warning to the Pfizer and Moderna coronavirus vaccines about extremely unusual cases of myocarditis — heart inflammation — in some young adults and teens after vaccination. Federal health officials said there was “a likely association,” and that the problem appears most likely to occur in young men after they receive two doses of the vaccine.

    The CDC and the Department of Health and Human Services, together with 15 of the country’s leading medical and public health organizations, issued a joint statement in June saying they “strongly encourage everyone 12 and older” to get the Pfizer and Moderna shots because the benefit of vaccination far exceeds potential harm.

    In June, the American Neurological Association reported that two studies published in the journal Annals of Neurology had found 11 cases of Guillain-Barré syndrome two to three weeks after vaccination with the AstraZeneca vaccine. The cases, which were from England and India, involved an unusual variant of the disease that caused severe facial weakness, the organization said. An accompanying editorial described a similar case involving a Boston man who received the Johnson & Johnson vaccine.

    Advertisement
    Vaccine safety officials in Europe have recommended that a warning be added about Guillain-Barré to the AstraZeneca vaccine. But the European safety committee said that while cases have been reported following vaccinations, “at this stage the available data neither confirms nor rules out a possible association with the vaccine.”

    The FDA revised its Johnson & Johnson fact sheet, urging vaccine recipients to seek immediate medical attention if they develop weakness or tingling, especially in the legs or arms, that worsens and spreads to other parts of the body; difficulty walking; difficulty with facial movements, including speaking, chewing or swallowing; double vision or inability to move the eyes; or difficulty with bladder control or bowel function.


    In 1976, there was a small increased risk of Guillain-Barré syndrome after people received the swine flu vaccine, which was a special shot for a potential pandemic strain of the influenza virus. A National Academy of Medicine review in 2003 found that people who received the 1976 swine flu vaccine had an increased risk of Guillain-Barré, with about one additional case for every 100,000 people who received the swine flu vaccine. The reason for the link remains unknown.

    Advertisement
    The CDC monitors for Guillain-Barré syndrome each flu season. The agency says the data on an association between the seasonal influenza vaccine and the illness varied from season to season. When there has been an increased risk, it has consistently been in the range of one or two additional cases per 1 million flu vaccine doses administered. Studies also suggest it is more likely that a person will get Guillain-Barré after getting the flu than after vaccination, according to the CDC.

    Read more:
     
  6. JanSz

    JanSz Gold

    upload_2021-7-23_11-39-21.png

    ...........................
     
    Marko Pollo and John Schumacher like this.
  7. JanSz

    JanSz Gold



    How a Doctor Cured Her Autoimmune Disease with Functional Medicine

    Oct 2, 2019
     
    John Schumacher likes this.
  8. JanSz

    JanSz Gold

  9. JanSz

    JanSz Gold

    Last edited: Jul 31, 2021
  10. JanSz

    JanSz Gold

  11. JanSz

    JanSz Gold

    Topology



    Why does this balloon have -1 holes?
    162,829 views
    Jul 30, 2021

    upload_2021-8-1_21-24-1.png

    upload_2021-8-1_21-26-3.png

    upload_2021-8-1_21-30-3.png
     
    Last edited: Aug 1, 2021
  12. JanSz

    JanSz Gold

    Risks and limitations of using excel spreadsheets.
    UK Government loses data because of Excel mistake.
    373,620 views
    Oct 9, 2020
     
    John Schumacher likes this.
  13. JanSz

    JanSz Gold

  14. JanSz

    JanSz Gold

    Need BTC to Hodl
    -----------------------------------------------------------
    You load sixteen tons, what do you get?
    Another day older and deeper in debt
    Saint Peter don't you call me 'cause I can't go
    I owe my soul to the company store

     
    John Schumacher likes this.
  15. JanSz

    JanSz Gold



    THE VEDIC GEOMETRY - A film based on research about Ancient Indian Geometry || Project SHIVOHAM
    580,944 views
    May 13, 2021

    . upload_2021-8-8_17-48-31.png
     
    Last edited: Aug 8, 2021
    John Schumacher likes this.
  16. JanSz

    JanSz Gold

  17. JanSz

    JanSz Gold



    Sapiens: A Brief History of Humankind by Yuval Noah Harari
    246,441 views
    Apr 1, 2021
    ..............................................................




    The Future of Humanity - with Yuval Noah Harari
     
  18. JanSz

    JanSz Gold



    MASS PSYCHOSIS - How an Entire Population Becomes MENTALLY ILL
    1,419,713 views
    Aug 3, 2021
    upload_2021-8-10_8-1-49.png

    upload_2021-8-10_8-9-17.png
     
    Last edited: Aug 10, 2021
  19. Josie Thomson

    Josie Thomson New Member

    @JanSz The one you purchased above we can also buy from USA Amazon. This one is what we want but the technology is very new.. surprise surprise!
    We called Philips today and they hadn't even heard of it. So what can we do.. ? I remember watching an oldish video of Jack talking about his daughter doing her homework in the kitchen where the lighting is a combination of the purple UVC light and a red bulb, I think that is correct.
    upload_2021-8-11_15-50-9.png
    UV-C disinfection upper air WM UV-C disinfection devices - Philips
     
  20. JanSz

    JanSz Gold

    And this I got from my memory. (Possibly we are talking about the same thing).
    Most important is that it is not about UVC
    it is about Black Light.
    Blacklight == who knows what, but something about UVA and UVB
    =========================================================
    PHYSICIAN GUEST BLOG #2: THE INVISIBLE SUN IN THE GULF SOUTH
    by
    Rob Hamilton, MD

    https://www.jackkruse.com/physician-guest-blog-2-the-invisible-sun-and-purple-light/

    https://www.batteriesplus.com/productdetails/cfl10028


    14W Black Light Spiral CFL Bulb
    CFL10028


    [​IMG]
    //////////////////////////////////////
     

Share This Page